A biomedical technology consortium that collaborates with the U.S. Army Medical Research and Development Command under an other transaction agreement might soon solicit proposals for innovative emerging technology prototypes that can be rapidly deployed—before the end of this year—to curb and combat the novel coronavirus.
The Medical Technology Enterprise Consortium, or MTEC, recently outlined aims to launch an expedited acquisition approach to trial and implement new technological solutions and unleash them into the real world to fight COVID-19 as soon as possible, and no later than Dec. 31.
The consortium published a presolicitation Sunday to notify interested stakeholders to begin preparing for one or several soon-to-come requests for project proposals.
“In light of the magnitude and potential threat that the [novel coronavirus] poses to our military’s health and readiness, the government seeks to rapidly accelerate the inquiry, testing, and fielding of new 21st century capabilities, employing novel technologies and approaches to the detection of exposure, prevention, containment and treatment of COVID-19 and future emerging threats,” officials wrote in the presolicitation.
As an internationally-dispersed consortium, MTEC partners with more than 300 organizations, including small and large companies, academic institutions, federal agencies, and nontraditional defense contractors to speed up and advance the creation of medical solutions that support the U.S. military. Entities often have to be consortium members to participate in prospective solicitations, but “due to the critical and urgent nature of the technical topic area” at hand, membership ..
Support the originator by clicking the read the rest link below.
